Schizophrenia/Psychosis

How do men versus women with schizophrenia fare clinically, functionally, and neuropsychologically over the long term?

Selfhood: a complex and continuously evolving identity that is anchored in the patient's history and dependent on language and memory. But there is so much more.

Although the clinical symptoms of psychotic disorders are dramatic and are what most clinicians focus on as their treatment targets, impairments in a wide range of cognitive function are observed in these illnesses.

The first-and-only transdermal patch for adults with schizophrenia offers a new treatment.

Be on the lookout for these novel psychoactive substances.

Preliminary studies suggest that adjuvant treatment with a statin may be beneficial for patients who are also prescribed psychotropic drugs for depression and schizophrenia.

In addressing mood disorders associated with infertility, sometimes the cure may be worse than the disease.

How can the best insights of mainstream and critical psychiatry be brought together?

The RISE study results look promising.

There is much to look forward to in the realm of improved treatments for patients with psychiatric illness.

Our basic science knowledge of the brain continues to explode beyond what science fiction of the past has predicted.

Hear details from the phase II trial of xanomeline-trospium and how it assists in the treatment of acute schizophrenia.

Navigating the treatment options for comorbid schizophrenia and alcohol use

Findings bring us closer to understanding schizophrenia that may enable clinicians to target symptoms.

Karuna Therapeutics shared exciting results from a Phase 2 trial on their lead agent.

Mutations in PCM1, a gene crucial to neuronal cilia function, have been connected with schizophrenia, according to a recent study.

Listen to discussion on results from a recent Phase 1b clinical trial.